Drug intelligence / Profile preview

Wumei Sanleng Decoction

Development stage: Preclinical
Lead developer: Nanjing University of Chinese Medicine
Administration: Oral

Overview

Wumei Sanleng Decoction is a Traditional Chinese Medicine (TCM) decoction currently under clinical investigation for the treatment of intestinal adenomatous polyps. As a TCM formulation, it is composed of a combination of various herbal ingredients, though the specific detailed composition and precise mechanism of action for this particular decoction are not explicitly provided in the available context. Its therapeutic approach is rooted in the principles of Traditional Chinese Medicine, aiming to restore physiological balance and address disease pathology through the synergistic effects of its herbal components.

Beyond the preview

Go deeper on Wumei Sanleng Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wumei Sanleng Decoction.

Explore the full profile